Lifecare ASA (OSL:LIFE)

Market Cap	132.96M -21.6%
Revenue (ttm)	6.64M -31.3%
Net Income	-119.51M
EPS	-6.81
Shares Out	298.12M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,048,391
Average Volume	11,497,609
Open	0.4500
Previous Close	0.4400
Day's Range	0.4320 - 0.4950
52-Week Range	0.3400 - 23.5000
Beta	-0.43
RSI	48.11
Earnings Date	May 14, 2026

About Lifecare ASA

Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures pressure, temperature, force, or various other performance indicators in live tissue; and medical devices that remove subdermal implants. Lifecare ASA ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 26
• Stock Exchange: Oslo Børs
• Ticker Symbol: LIFE

Financial Performance

In 2025, Lifecare ASA's revenue was 6.64 million, a decrease of -31.34% compared to the previous year's 9.67 million. Losses were -119.51 million, 66.6% more than in 2024.